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ABSTRACT 
 
 
 
Curtis, Courtney L. M.S., Purdue University, August 2013.  Wnt Signaling in Zebrafish 
Fin Regeneration: Chemical Biology Using a GSK3β Inhibitor.  Major Professor:  James 
A. Marrs. 
 
 
 
Bone growth can be impaired due to disease, such as osteoporosis.  Currently, 
intermittent parathyroid hormone (PTH) treatment is the only approved therapy in the 
United States for anabolic bone growth in osteoporosis patients.  The anabolic effects of 
PTH treatment are due, at least in part, to modulation of the Wnt/β-catenin pathway.  
Activation of the Wnt/ β-catenin pathway using a small molecule inhibitor of GSK3β was 
previously shown to increase markers of bone formation in vitro.  Our study utilized a 
zebrafish model system to study Wnt activated fin regeneration and bone growth. Wnt 
signaling is the first genetically identified step in fin regeneration, and bony rays are the 
main structure in zebrafish fins.  Thus, zebrafish fin regeneration may be a useful model 
to study Wnt signaling mediated bone growth.  Fin regeneration experiments were 
conducted using various concentrations of a GSK3β inhibitor compound, LSN 2105786, 
for different treatment periods and regenerative outgrowth was measured at 4 and 7 days 
post amputation.  Experiments revealed continuous low concentration (4-5 nM) treatment 
to be most effective at increasing regeneration.  Higher concentrations inhibited fin 
growth, perhaps by excessive stimulation of differentiation programs.  In situ 
viii 
 
hybridization experiments were performed to examine effects of GSK3β inhibitor on Wnt 
responsive gene expression.  Experiments showed temporal and spatial changes on 
individual gene markers following GSK3β inhibitor treatment.  Additionally, confocal 
microscopy and immunofluorescence labeling data indicated that the Wnt signaling 
intracellular signal transducer, β-catenin, accumulates throughout GSK3β inhibitor 
treated tissues.  Finally, experiments revealed increased cell proliferation in fin 
regenerates following LSN 2105786 treatment.  Together, these data indicate that bone 
growth in zebrafish fin regeneration is improved by activating Wnt signaling.  Zebrafish 
Wnt signaling experiments provide a good model to study bone growth and bone repair 
mechanisms, and may provide an efficient drug discovery platform. 
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CHAPTER 1:  INTRODUCTION 
 
 
 
Zebrafish Fin Regeneration 
Whereas mammals are limited in their ability to regenerate damaged tissues and are 
unable to repair bone fractures beyond a critical size, zebrafish possess the ability to 
completely regenerate complex structures, such as the bony rays of the fin.  While 
zebrafish are able to regenerate all fin types, the accessibility of the caudal fin for surgery 
and measurement has made it an important model for use in regeneration studies.  The 
zebrafish caudal fin is comprised primarily of lepidotrichia, segmented bony rays which 
consist of two concave hemirays that surround fibroblast like cells, nerves and blood 
vessels, and are covered by a single layer of osteoblasts on both the inner and outer 
surface (Figure 1) (Poss, Keating et al. 2003).  When subjected to injury, such as 
amputation, the zebrafish fin regenerates rapidly.  If half of the caudal fin is amputated, 
the fin is restored to its original length by approximately 3 weeks post amputation.  The 
new bones of the regenerate are formed without a cartilage intermediate in a process that 
is analogous to intramembranous bone formation (Knopf, Hammond et al. 2011).  This 
remarkable ability makes zebrafish an ideal model to study the molecular mechanisms of 
bone growth and repair. 
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Zebrafish fin regeneration occurs through three general stages: (1) wound healing, (2) 
formation of a blastema consisting of mesenchymal progenitors, and (3) regenerative 
outgrowth and patterning of bony ray structures (Figure 2).  The initial stage, wound 
healing, begins within 1 to 3 hours post amputation (hpa).  This process occurs without 
cell proliferation and is achieved by migration of epidermal cells to form a thin layer 
covering the wound by 12 hpa (Poleo, Brown et al. 2001).  As wound healing progresses, 
additional layers are added to the wound epidermis and it begins to express genes that 
play a role in growth and patterning.  Over the course of the next 24-36 hours, a blastema 
forms at the distal tip of each amputated fin ray (Akimenko, Marí-Beffa et al. 2003).  The 
blastema is comprised of proliferative mesenchymal progenitor cells which will 
eventually develop into the new structures of the regenerated fin.  Although the source of 
the cells which give rise to the blastema is not entirely clear, it is formed, at least in part, 
by mature osteoblasts and fibroblasts which dedifferentiate, proliferate, and migrate 
distally (Poleo, Brown et al. 2001; Knopf, Hammond et al. 2011).  Beginning at 
approximately 48 hpa, fin regeneration enters the outgrowth and patterning stage.  During 
this stage, the blastema can be divided into two domains, the distal blastema and the 
proximal blastema.  The distal blastema proliferates extremely slow and is thought to 
play a role in directing outgrowth (Nechiporuk and Keating 2002).  In contrast, the 
proximal blastema is intensively proliferative.  As the cells in proximal blastema 
proliferate, they migrate to the area immediately proximal and begin to differentiate into 
osteoblasts which secrete the matrix to form the new bone segment (Poss, Keating et al. 
2003).  The fin continues to rapidly regenerate until the original length is restored, at 
which point growth slows via a process that is not well characterized. 
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Wnt/β-catenin Signaling Pathway 
Wnt ligands are cysteine-rich, secreted glycoproteins with crucial roles in embryonic 
development and regulation of cell growth, differentiation, and apoptosis (Moon, 
Bowerman et al. 2002).  Wnt signaling can be divided into two general pathways, the 
canonical Wnt/β-catenin signaling pathway and the non-canonical β-catenin independent 
Wnt signaling pathway.  The canonical Wnt signaling pathway is activated when the Wnt 
ligand binds to a transmembrane Frizzled (Fz) receptor and the co-receptors low density 
lipoprotein receptor-related proteins – 5/6 (LRP 5/6).  Receptor engagement activates 
Dishevelled family proteins (Dsh), which in turn, inhibit the cytoplasmic “destruction 
complex” consisting of Axin, adenomatous polyposis coli (APC) and glycogen synthase 
kinase 3β (GSK3β). Inactivation of the “destruction complex” prevents phosphorylation 
of β-catenin by GSK3β, a modification that marks it for degradation (Figure 3).  As a 
result, unphosphorylated β-catenin accumulates in the cytoplasm and translocates to the 
nucleus where it displaces histone deacetylase (HDAC) corepressors from T-cell factor/ 
Lymphoid enhancer factor (TCF/LEF), recruits histone acetylases (HAT), and activates 
Wnt target genes.  In the absence of the Wnt ligand, β-catenin is phosphorylated by 
GSK3β and subsequently degraded (Agholme and Aspenberg 2011). 
 
There are several proteins that are known to play an antagonistic role in the Wnt/β-
catenin signaling pathway.  Most notable are the Dickkopfs (Dkks), sclerostin (SOST), 
and secreted Frizzled-related proteins (SFRPs).  Dkks bind to the LRP-5/6 co-receptor 
blocking the formation of the Wnt-Fz-LRP 5/6 complex, which is necessary for the 
activation of Dsh.  In addition, Dkks interact with Kremens (Krm) which form a Dkk-
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Krm-LRP 5/6 complex that is thought to be internalized and degraded in the lysosome 
(Westendorf, Kahler et al. 2004).  Similar to Dkks, SOST inhibits Wnt signaling by 
binding the LRP 5/6 co-receptor (Semënov, Tamai et al. 2005). SFRPs antagonize Wnt 
signaling by directly binding the Wnt ligand (Semënov, Tamai et al. 2005). 
 
Wnt/β-catenin Signaling in Zebrafish Fin Regeneration 
Wnt/β-catenin signaling is the earliest genetically identified step in fin regeneration and is 
required during all stages of regeneration for normal outgrowth to occur (Stoick-Cooper, 
Weidinger et al. 2007).  The Wnt ligand, Wnt-10a, which signals through the canonical 
Wnt pathway, is upregulated during the first few hours following amputation (Stoick-
Cooper, Weidinger et al. 2007).  At the same time, β-catenin expression is detectable in 
the cells of the wound epidermis, where it is maintained throughout regeneration.  
Additionally, the Wnt/β-catenin signaling target Lef1 is expressed in the wound 
epidermis as early as 12 hpa (Poss, Shen et al. 2000).  Previous studies have shown that 
inhibition of fibroblast growth factor (FGF) signaling does not affect expression of lef1, 
but inhibition of Wnt/β-catenin signaling is sufficient to repress expression of FGF target 
genes (Kawakami, Esteban et al. 2006).  Taken together, these findings indicate that 
Wnt/β-catenin signaling is upstream of FGF signaling and later differentiation pathways, 
such as Shh and Bmp2b signaling, which direct blastema cells to differentiate into 
osteoblasts (Kulkarni, Halladay et al. 2005; Stoick-Cooper, Moon et al. 2007). 
 
In addition to a role in the immediate regenerative response, Wnt/β-catenin signaling is 
also important in establishment of the blastema.  In studies using a transgenic zebrafish 
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line, the Wnt/β-catenin signaling transcriptional reporter, TOPdGFP, is detectable in the 
blastema by 48 hpa.  Furthermore, expression levels of several direct Wnt/β-catenin 
target genes, such as axin2 and sp8, are upregulated in the regenerating tissue during 
blastema formation (Stoick-Cooper, Weidinger et al. 2007).  During this stage of 
regeneration, interactions between Wnt/β-catenin signaling and FGF signaling are critical 
for establishing the blastema.  Disruption of the Wnt target, FGF receptor 1 (FGFR1), 
prevents expression of cellular proliferation markers and completely blocks blastema 
formation (Poss, Shen et al. 2000). 
 
Experiments which utilized a heat shock inducible Dkk transgenic to inhibit Wnt/β-
catenin signaling at various times post amputation revealed the necessity of Wnt/β-
catenin signaling during each stage of regeneration.  Inhibition of Wnt/β-catenin 
signaling at 0 or 1 dpa does not affect epidermal wound healing, but prevents blastema 
formation and subsequent regenerative outgrowth.  When Wnt/β-catenin signaling is 
disrupted after the blastema has already formed, fins display only partial regeneration, 
indicating that Wnt/β-catenin signaling is also involved in blastema maintenance and 
regulation of outgrowth.  Conversely, over activation of Wnt/β-catenin signaling results 
in enhanced fin regeneration rate.  Fish with a mutation in one copy of the Wnt/β-catenin 
pathway inhibitor, axin1, display increased regenerative outgrowth at 7 dpa (Stoick-
Cooper, Weidinger et al. 2007). 
 
Interestingly, disruption of β-catenin independent Wnt signaling affects fin regeneration 
as well.  Inhibition of the β-catenin independent Wnt signaling pathway results in 
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increased regenerative outgrowth, whereas over activation of β-catenin independent Wnt 
signaling completely blocks fin regeneration (Stoick-Cooper, Weidinger et al. 2007).  
These findings suggest a model in which β-catenin independent Wnt signaling acts in a 
negative-feedback loop to antagonize Wnt/β-catenin signaling and regulate regeneration.  
 
Wnt/β-catenin Signaling in Mammalian Bone Formation and Fracture Repair 
In recent years, the Wnt signaling pathway has been shown to be an important player in 
bone formation, homeostasis, and repair.  Early indications that canonical Wnt signaling 
may play a role in bone formation were revealed by finding natural mutations in the LRP 
5/6 co-receptor.  Loss of function mutations in the LRP 5/6 co-receptor were shown to 
cause osteoporosis-pseudoglioma syndrome, a disorder in which patients have 
significantly lower bone mass and an increased risk of fracture (Gong, Slee et al. 2001).  
Conversely, activating mutations which prevent binding of the Wnt antagonist Dkk to the 
LRP 5/6 co-receptor result in a high bone mass phenotype with no other obvious defects 
(Boyden, Mao et al. 2002).  These observations laid the foundation for studying the role 
of Wnt signaling in bone formation and led to examination of the role other key 
components of the Wnt signaling pathway play in bone formation. 
 
Wnt/β-catenin signaling plays a crucial role in bone formation by regulating osteoblast 
differentiation and suppressing osteoclast activity (Holmen, Zylstra et al. 2005; Spencer, 
Utting et al. 2006).  Several studies have demonstrated that β-catenin is necessary for 
mesenchymal progenitors to ultimately differentiate to osteoblasts.  A study using mouse 
embryos with a conditional knock out of β-catenin, specifically in the mesenchymal 
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progenitors of chondrocytes and osteoblasts, revealed that E 18.5 mutant embryos display 
a skeleton in which cartilage is present but bone is entirely lacking (Hu, Hilton et al. 
2005).  A similar study confirmed these results and presented evidence that knocking out 
β-catenin in osteoblast precursors arrests differentiation and causes the osteoblasts to 
transdifferentiate into chondrocytes (Hill, Später et al. 2005).  While inactivating β-
catenin has an inhibitory effect on osteogenesis, ectopic expression of Wnt-14, a 
canonical Wnt signaling pathway ligand, in early mouse embryos produced enhanced 
osteogenesis and expansion of osteoblast markers such as Runx2, Osterix, and 
Osteocalcin (Day, Guo et al. 2005).  Wnt-10b, another ligand of the canonical Wnt 
signaling pathway, plays an important role in stimulating osteoblastogenesis and 
inhibiting adipogenesis.  In mesenchymal progenitors Wnt-10b induces expression of 
Runx2 and Osterix while at the same time inhibiting expression of adipogenic factors 
such as peroxisome proliferator-activated receptor γ (PPARγ), thus promoting 
osteoblastogenesis in favor of adipogenesis (Bennett, Ouyang et al. 2007). 
 
In addition to a role in skeletal development, canonical Wnt signaling was also implicated 
in the fracture healing process.  Data from RT-PCR and gene microarrays have shown 
that multiple Wnt ligands, along with several components of the Wnt/β-catenin pathway 
were upregulated during the early stages of fracture repair.  During these early stages, β-
catenin levels were increased and remained elevated throughout fracture repair before 
ultimately declining to basal levels as healing completes (Zhong, Gersch et al. 2006).  
The importance of canonical Wnt signaling in fracture repair was further shown by 
studies evaluating the effects of Dkk1 on fracture repair, which showed that inhibition of 
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the Wnt/β-catenin signaling pathway during the first week immediately following injury 
blocks healing, leaving undifferentiated mesenchymal tissue in place of a callus at the site 
of injury (Chen, Whetstone et al. 2007). 
 
Wnt/β-catenin Pathway as a Therapeutic Target 
The majority of bone fractures heal with minimal intervention, however, a small 
percentage of fractures fail to heal properly (Secreto, Hoeppner et al. 2009).  Therapies 
designed to induce bone formation could be the key to a shorter, more effective healing 
process for these patients.  Moreover, these same therapies could be applied to 
osteoporosis patients who are at especially high risk of fractures due to low bone mass 
and poor bone quality. 
 
Currently, intermittent parathyroid hormone (PTH) treatment is the only approved 
therapy in the United States for anabolic bone growth in osteoporosis patients (Secreto, 
Hoeppner et al. 2009).  Recent studies have revealed that the anabolic effects of PTH 
treatment are due, at least in part, to modulation of the Wnt/β-catenin pathway (Kulkarni, 
Halladay et al. 2005).  While parathyroid hormone treatment is effective in increasing 
bone mass, direct modulation of the Wnt/ β-catenin pathway may be a safer and more 
efficient way to stimulate bone repair and regeneration.  Activation of the Wnt/ β-catenin 
pathway using a small molecule inhibitor of GSK3β was previously shown to increase 
markers of bone formation in vitro as well as increase bone mass in vivo.  GSK3β 
inhibitor treatment increased markers of osteoblast differentiation and was sufficient to 
increase both bone mineral density (BMD) and bone mineral content (BMC) in 
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osteopenic rats (Kulkarni, Onyia et al. 2006).  Collectively, this data points to modulation 
of the Wnt/ β-catenin pathway as an important area of future research for bone repair and 
regeneration. 
 
Research Goals 
The goal of this research was to evaluate a zebrafish fin regeneration research model for 
Wnt mediated bone growth.  Wnt signaling is the first genetically identified step in fin 
regeneration, and bony rays are the main differentiated cell type in fins. Thus, zebrafish 
fin regeneration may be a useful model to study Wnt signaling mediated bone growth.  
Our hypothesis was that zebrafish Wnt mediated signaling experiments will model 
human bone growth and repair, and provide a versatile drug discovery platform.  
Specifically, we wanted to analyze the effects of activating Wnt/β-catenin signaling, via 
GSK3β inhibition, on the regenerative response to injury in the zebrafish fin. GSK3β is a 
well-established drug target for regulating Wnt signaling, and zebrafish GSK3β is very 
similar to human GSK3β.  Human GSK3β contains 420 amino acids versus 421 in 
zebrafish GSK3β.  A 408 amino acid core in the protein is 95% identical between human 
and zebrafish sequences. 
 
Our hypothesis was tested by analyzing the effects of various GSKβ inhibitor treatment 
regimens on zebrafish caudal fin regeneration.  More specifically, we aimed to measure 
the effects of GSK3β inhibitor treatment on fin regeneration rate and dissect the cellular 
and molecular mechanisms of bone growth responses.  We examined the rate of 
regeneration in response to Wnt/β-catenin signaling activation by measuring regenerative 
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outgrowth at 4 and 7 dpa.  Additionally, we evaluated the spatial and temporal effects of 
GSKβ inhibitor treatment on Wnt responsive gene expression using in situ hybridization.  
Using immunostaining, the effects of GSK3β inhibitor treatment on cell proliferation and 
β-catenin accumulation were assessed.  
11 
 
 
 
 
 
 
CHAPTER 2:  MATERIALS AND METHODS 
 
 
 
Adult Fin Amputation and GSK3β Inhibitor Treatment 
Zebrafish, 6-12 months of age, were obtained from EKKWill Waterlife Resources 
(Ruskin, FL) and used in fin regeneration experiments.  Fish were anesthetized in tricaine 
(Ethyl 3-aminobenzoate methanesulfonate) and 50% of the caudal fin was amputated 
using a razor blade.  Fish were placed in 2 liters of water with various concentrations of 
GSK3β inhibitor compound (LSN 2105786) or DMSO vehicle control and kept at 31°C 
to promote rapid regeneration.  Tank water was replaced, and fresh compound was added 
daily.  Tanks and fish were rinsed between treatments to remove any residual compound.  
 
Embryo GSK3β Inhibitor Treatment 
Embryos were exposed to LSN 2105786 by incubation in embryo medium containing 
various concentrations of LSN 2105786 from 6-28 hours post fertilization (hpf), in Petri 
dishes wrapped with parafilm and maintained at 28.5ºC.  Images were collected using 
using a Leica MZ12 microscope equipped with Leica DFC290 camera (Leica 
Microsystems Inc., Buffalo Grove, IL USA). 
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Fin Regeneration Measurements 
At 4 and 7 dpa, fish were anesthetized and images of regenerating fins were collected 
using a Leica MZ12 microscope equipped with Leica DFC290 camera (Leica 
Microsystems Inc., Buffalo Grove, IL USA).  The length of the regenerate (from the 
amputation plane to the distal tip of the fin) at the third, fourth and fifth dorsal and ventral 
fin rays were measured using IMAGE J software (NIH, http://rsb.info.nih.gov/ij/) and the 
average length of the regenerate calculated for each fish. 
 
Whole-Mount In Situ Hybridization 
Fins were collected at various time points post amputation and fixed overnight at 4°C in 
4% paraformaldehyde in phosphate-buffered saline (PBS).  Fins were briefly washed two 
times in PBS, then dehydrated in methanol and stored at 20°C overnight.  Fins were 
rehydrated stepwise in methanol in PBS– 0.1% Tween 20 (PBT), followed by 30 minute 
incubation with 10 μg/ml proteinase K in PBT.  Then, fins were washed two times in 
PBT and refixed in 4% paraformaldehyde in PBS for 20 minutes.  Fins were washed five 
times in PBT, and then prehybridized for 2 hours at 70°C in hybridization buffer (50% 
formamide, 5x SSC, 0.1% Tween 20, 50 μg/ml heparin, and 500 μg/ml yeast RNA).  
Following prehybridization, fins were hybridized overnight in hybridization buffer 
including 0.5 μg/m l digoxigenin-labeled RNA probe at 70°C.  Then, fins were washed at 
70°C for 10 minutes each in 75% hybridization buffer/25% 2x SSC, 50% hybridization 
buffer/50% 2x SSC, 25% hybridization buffer/75% 2x SSC, and 2x SSC.  Next, fins were 
washed two times in 0.05x SSC for 30 minutes each at 70°C, followed by washes at room 
temperature for 5 minutes each in 75% 0.05x SSC/25% PBT, 50% 0.05x SSC/50% PBT, 
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25% 0.05x SSC/75% PBT, and PBT.  After 2 hour incubation at room temperature in 
block buffer (2 mg/ml bovine serum albumin in PBT), fins were incubated overnight in a 
1:5,000 dilution of anti-digoxigenin antibody coupled to alkaline phosphatase in block 
buffer.  The following day, fins were washed with PBT 5 times for 15 minutes each.  Fins 
were then washed with alkaline phosphatase buffer (NTMT) 3 times for 15 minutes each, 
followed by incubation with NBT/BCIP substrate in NTMT to allow color development.  
The development of the staining reaction was monitored carefully, and treated and 
control fins were stopped at the same time to allow accurate comparison.  Following 
color development, fins were washed 5 times in PBT and stored in 80% glycerol in PBT.  
Digoxigenin-labeled riboprobes for shh, lef1, bmp2b, bmp4, and sox9b were synthesized 
using DIG RNA Labeling Kit (Roche, Indianapolis, IN USA) according to 
manufacturer’s recommendations.  Images were collected using a Leica MZ12 
microscope equipped with Leica DFC290 camera. 
 
Whole-Mount Immunostaining 
Fins were collected at various time points post amputation and fixed overnight at 4°C in 
4% paraformaldehyde in phosphate-buffered saline (PBS).  Following fixation, fins were 
briefly washed several times with PBS.  Next, fins were incubated overnight at room 
temperature in block solution.  Next, fins were incubated with primary antibody in block 
solution for 1-3 days.  Primary antibodies used were: mouse anti-Zns 5 (Zebrafish 
International Resource Center, Eugene, OR, USA) at 1:200; mouse anti-β-catenin 
(Sigma-Aldrich) at 1:300; rabbit anti-phospho-histone H3 (Chemicon International, Inc.) 
at 1:500.  After incubation in primary antibody, fins were washed with PBT 6 times for 
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10 minutes each, and then incubated overnight with secondary antibody in block solution.  
Secondary antibodies used were: goat anti-mouse Alexa 488 (Invitrogen); goat anti-
mouse Texas Red (Invitrogen); and goat anti-rabbit Alexa 488 (Invitrogen).  Fins were 
then washed with PBS 4 times for 10 minutes each, and incubated with 1 μM TO-PRO-3 
Iodide for 1 hour at room temperature to visualize nuclei.  Confocal images were 
acquired using a Zeiss Observer Z1 LSM 700 confocal microscope (40X 1.1 NA W or 
20X 0.8 NA objectives; Carl Zeiss Microscopy, Thornwood, NY USA). 
 
Cell Proliferation Analysis 
Fin regenerates were collected at 1 and 2 dpa and stained using anti-phospho-histone H3 
antibody, as described above.  Phospho-histone 3 (PH3)-positive cells were counted from 
at least 3 fins per group.  The number of PH3-positive cells per unit area was calculated 
for each fin. 
 
β-catenin Staining Analysis 
Fin regenerates were collected at 3 dpa and stained using anti-β-catenin antibody, as 
described above.  Intensity measurements in the regenerating fin rays were made with 
ImageJ Software along rectangular (ray matched) regions of interest in the tissue 
immediately distal to the amputation plane. 
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Statistical Analysis 
Analyses on fin regenerate length, fluorescence intensity, and cell proliferation were 
performed using unpaired two-tailed Student's t-test (GraphPad Software, La Jolla, CA 
USA).  
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CHAPTER 3:  RESULTS 
 
 
 
GSK3β Inhibition Increases Fin Regeneration Rate 
To test the effects of enhanced Wnt/β-catenin signaling on the rate of zebrafish fin 
regeneration, we treated fish with a small molecule GSK3β inhibitor (LSN 2105786).  
Fish were treated for different treatment periods (1-24 hours per day) at various 
compound concentrations following caudal fin amputation.  Half of the caudal fin was 
amputated and fish were kept in tanks at 31°C with or without compound present during 
the 7 days immediately following amputation.  To determine an optimal dosing regimen 
for maximal regenerative outgrowth at 4 and 7 dpa, fish were treated continuously with 
low concentrations (1-30 nM) or intermittently with higher concentrations (30-300 nM) 
of LSN 2105786.  Experiments showed that continuous exposure using low 
concentrations (4-5 nM) were most effective at increasing regeneration.  In both the 4 nM 
and 5 nM continuous treatment groups, fin regenerates were significantly longer than 
control fins at 4 and 7 dpa.  Control regenerates were an average length of 1.00 mm at 4 
dpa compared to 1.18 mm and 1.16 mm for the 4 nM and 5 nM treatment groups, 
respectively (Figure 4).  This trend continued through 7 dpa, at which point control 
regenerates averaged 1.72 mm whereas the 4 nM and 5 nM treatment groups displayed 
average lengths of 1.85mm and 1.95 mm, respectively (Figure 2). 
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Surprisingly, we did not observe any consistent effect on fin regenerate length with 
intermittent treatment (1 or 6 hours per day at various concentrations).  Interestingly, 
continuous treatment with higher concentrations of LSN 2105786 inhibited fin growth. 
 
LSN 2105786 Treatment Recapitulates Ectopic Wnt Signaling Phenotype 
To confirm that LSN 2105786 was acting upon the target enzyme, GSK3β, in zebrafish, 
we treated embryos with various concentrations (300 nM – 5 μM) of LSN 2105786 from 
6-28 hours post-fertilization (hpf) and analyzed the resulting phenotypes.  It was 
previously shown that ectopic Wnt signaling produces a phenotype in which embryos are 
eyeless or the size of the eye is dramatically reduced (van de Water, van de Wetering et 
al. 2001).  Treatment with LSN 2105786 was able to recapitulate these phenotypes, 
producing eye defects in a dose dependent manner, with the highest concentrations 
resulting in 100% eyeless embryos.  The lower concentrations used resulted in variable 
defects, ranging from eyes that were nearly normal in appearance to eyes that were 
reduced in size, or in some cases completely absent (Figure 5).  
 
GSK3β Inhibition Augments Expression of Wnt Target Genes 
To determine the spatial and temporal effects of GSK3β inhibition on Wnt responsive 
gene expression in fin regenerates, we utilized in situ hybridization to examine the 
expression of the direct Wnt/β-catenin target gene, lef1, and several downstream genes: 
shh, bmp2b, and bmp4.  Since continuous LSN 2105786 treatment at a concentration of 5 
nM produced consistent increases in regenerative outgrowth, this concentration was used 
for in situ hybridization experiments. 
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We examined the expression of lef1 at 1, 2, and 3 dpa in control and GSK3β inhibitor 
treated tissue.  Previous studies demonstrated that lef1 is expressed in the basal epidermal 
layer surrounding the blastema at 1 dpa and is thought to be involved in blastema 
formation.  During the regenerative outgrowth phase (48 hpa and beyond), lef1is 
expressed in the distal blastema and two sets of cells on each side of the fin ray (Poss, 
Shen et al. 2000).  In our experiments, lef1 transcripts appeared to be more strongly 
expressed, and the expression domain expanded in the treated group at both 1 and 2 dpa 
(Figure 4).  At 1 dpa, lef1 is restricted to the area immediately surrounding the blastema 
in control fins; whereas, LSN 2105786 treated fins showed an expansion of lef1 
expression in to the wound epidermis and interray tissue.  Interestingly, at 3 dpa, 
differences in staining intensity were less pronounced.  However, lef1 was detected 
proximal to the blastema, in the newly formed bone ray, in the treated group but 
undetectable in the same region of control fins (Figure 6). 
 
We then tested the effects of LSN 2105786 treatment on expression of shh, a downstream 
target involved in bone differentiation pathways (Quint, Smith et al. 2002).  Similar to 
lef1, shh expression is typically restricted to two sets of cells on each side of the distal tip 
of the fin ray during the regenerative outgrowth phase.  In the LSN 2105786 treated 
group, an expansion of the shh expression domain was observed at 3 dpa, with shh 
transcripts being detectable in the tissue proximal to the blastema and extending to near 
the amputation plane (Figure 7).   
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The bone morphogenetic protein (BMP) family members, Bmp4 and Bmp2b, were 
previously shown to regulate skeletal development and patterning (Wan and Cao 2005).  
These signaling molecules play a role in osteoblast differentiation and maturation during 
bone formation (Canalis 2003).  Previous studies revealed that both bmp2b and bmp4 are 
expressed in the regenerating zebrafish caudal fin and disruption of BMP signaling 
results in decreased bone formation (Laforest, Brown et al. 1998; Murciano, Fernández et 
al. 2002; Smith, Avaron et al. 2006).  During regeneration, bmp4 is expressed in the distal 
blastema where it likely plays a role in controlling proliferation and regenerative 
outgrowth (Murciano, Fernández et al. 2002).  In contrast, bmp2b is expressed in newly 
differentiating osteoblasts in the area of the proximal blastema, indicating that it 
contributes to bone formation (Laforest, Brown et al. 1998). 
 
Our results showed faint expression of bmp4 in control tissues at 3 dpa, whereas treated 
tissues displayed robust expression and a slightly expanded expression domain (Figure 
6).  At 4 dpa, expression of bmp4 remained higher in treated fins as compared to controls 
at the same time point.  Additionally, in treated fins bmp4 was expressed in the distal 
most epidermis; whereas, it was undetectable in the same region of control fins (Figure 
8). 
 
Expression of bmp2b was not dramatically altered in response to LSN 2105786 treatment 
at the time points analyzed.  At 3 dpa, expression in treated fins was nearly 
indistinguishable from that of controls (Figure 9).   
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GSK3β Inhibition Effects on Cell Proliferation 
We next investigated the effects of GSK3β inhibition, using 5 nM LSN 2105786 
continuously, on cell proliferation in the regenerating fin tissue.  Anti-phosphorylated 
histone H3 (PH3) antibody staining, a marker for chromosome condensation during 
mitosis, was used to determine the number of proliferating cells in fin regenerates at 1 
and 2 dpa.  PH3 positive cells were counted in the regenerating tissue of both control and 
treated fins, and a “nuclei per unit area” value was calculated for each fin.  At 1 dpa, the 
number of proliferating cells counted in treated and control fins was nearly identical 
(Figure 10).  However, on the 2nd day following amputation, treated fins displayed a 
markedly higher number of proliferating cells than controls (Figure 11). There was an 
approximately 3 fold increase in the number of PH3-positive cells in treated fins relative 
to control at this time point (Figure 10). 
 
GSK3β Inhibition Alters β-catenin Accumulation in Regenerating Tissue 
The end point of Wnt/β-catenin signaling is stabilization and accumulation of β-catenin.  
To test the effects of LSN 2105786 treatment on β-catenin accumulation in regenerating 
fin tissue, fins were stained using a monoclonal anti-β-catenin antibody.  Fish were 
treated continuously with either DMSO vehicle or LSN 2105786 at the following 
concentrations; 1 nM, 3 nM, 6 nM, 10 nM, or 15 nM.  Immunofluorescence intensity was 
measured at 3 dpa in an identically sized region, beginning at the amputation plane and 
extending distally, in the 2nd and 3rd lateral rays of each fish. 
 
21 
 
LSN 2105786 treatment produced a dose dependent effect on immunofluorescence 
intensity (Figure 10).  Immunofluorescence intensity was highest in the 6 nM treated 
group, which exhibited a 37% increase in average intensity over the DMSO vehicle 
treated control group (Figure 12). Interestingly, the highest concentration analyzed, 15 
nM, produced a decrease in β-catenin expression.  However, variation was high among 
all treatment groups and statistical analysis did not yield statistically significant 
differences. 
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CHAPTER 4:  DISCUSSION 
 
 
 
This research has demonstrated that zebrafish fin regeneration is a useful model for 
studying Wnt mediated bone growth and repair, and may provide an efficient drug 
discovery platform.  Although it has been used extensively in developmental and genetic 
studies, zebrafish has only recently been widely utilized as a model in pharmacological 
studies.  The small size, ease of care, and relatively low cost of zebrafish give this model 
the potential to be adapted for large scale bone therapeutic compound screening.  Fin 
regeneration studies allow the generation of large amounts of data in a relatively short 
period of time compared to other bone repair models. 
 
Our research shows that zebrafish fin regeneration is responsive to Wnt/β-catenin 
signaling modulation via GSK3β inhibition.  In agreement with previous studies by 
Stoick-Cooper et al, our findings showed that enhanced Wnt/β-catenin signaling 
increases regenerative outgrowth in the zebrafish caudal fin (Stoick-Cooper, Weidinger et 
al. 2007).  LSN 2105786 treated fish displayed as much as a 13% increase in regenerate 
length at 7 dpa as compared to DMSO vehicle treated controls.  Similarly, it was 
previously shown that over activation of Wnt/β-catenin signaling in axin1 heterozygous 
mutant fish produced a 10.5% increase in regenerative outgrowth compared to wild type 
fish at the same time point (Stoick-Cooper, Weidinger et al. 2007).  Interestingly, our 
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results using intermittent LSN 2105786 treatment are in agreement with previously 
published data as well.  It was previously shown that pulsed activation of a wnt8 
transgene was sufficient to increase cell proliferation, but did not affect the length of fin 
regenerates (Stoick-Cooper, Weidinger et al. 2007). 
 
The inhibitory effects on regeneration observed following continuous LSN 2105786 
treatment at higher concentrations invite speculation that extreme over activation of the 
Wnt/β-catenin pathway may excessively stimulate differentiation programs, thus 
depleting the progenitor cell population and preventing outgrowth.  Further studies aimed 
at determining the threshold at which Wnt/β-catenin signaling over activation transitions 
from a stimulatory to an inhibitory factor of regeneration, and dissecting the molecular 
mechanisms regulating that process, could provide valuable insight to the role of Wnt 
signaling in the regenerative process.  
 
Since zebrafish can regenerate fins normally, without intervention, the extent to which 
regenerative outgrowth can be augmented in healthy fish is limited.  Fin regenerate length 
may not be sensitive enough to detect subtle variations of compound efficacy in normal, 
healthy fish.  Fish that are defective in the regenerative process, or display abnormal bone 
phenotypes, perhaps due to aging, chronic alcohol, or chronic nicotine, may show a more 
dramatic response to Wnt/β-catenin signaling modulation, and thus provide more insight 
into bone repair mechanisms. 
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The ability of LSN 2105786 treatment to recapitulate previously characterized ectopic 
Wnt signaling phenotypes is consistent with LSN 2105786 acting upon the target 
enzyme, GSK3β, in zebrafish.  Additionally, upregulation of the direct Wnt target, lef1, 
and accumulation of β-catenin in regenerating tissue provide strong evidence that LSN 
2105786 treatment activates Wnt/β-catenin signaling during fin regeneration.  Our 
attempts to directly measure GSK3β inhibitor effects using a Wnt/β-catenin signaling 
transcriptional reporter, TOPdGFP, zebrafish transgenic line were unsuccessful.  LSN 
2105786 was fluorescent and detected at the same wavelength as GFP, thus preventing 
quantification of GFP expression changes in response to LSN 2105786 treatment.  Future 
studies using an alternative Wnt/β-catenin signaling transcriptional reporter, such as RFP 
or YFP, could be utilized to directly measure these effects. 
 
LSN 2105786 treatment was sufficient to increase cell proliferation and augment 
expression of important downstream genes.  One important observation from our in situ 
hybridization experiments was the upregulation of bmp4 in response to LSN 2105786 
treatment.  Given the role bmp4 plays in controlling blastema cell proliferation and 
outgrowth, it is likely that upregulation of bmp4 expression plays a role in the increased 
cell proliferation and subsequent increased regenerative outgrowth observed following 
continuous LSN 2105786 treatment. 
 
Additionally, expression of the bone differentiation pathway member, shh, was expanded 
at 3 dpa.  shh is widely purported to be involved in the proliferation and alignment of 
osteoblasts in the regenerating fin.  Ectopic expression of shh in the interray tissue was 
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previously shown to induce bone formation and lead to fusion of adjacent rays (Quint, 
Smith et al. 2002).  Furthermore, it was previously shown that down regulation of shh 
using cyclopamine, a known inhibitor of shh signaling, drastically reduced regenerative 
outgrowth (Quint, Smith et al. 2002).   
 
The in situ hybridization experiments performed during this research provide semi-
quantitative data regarding gene expression changes following LSN 2105786 treatment; 
future quantitative PCR assays could be utilized to evaluate these responses with more 
precision.  Quantitative PCR assays for additional genes involved in osteoblast 
differentiation, such as runx2, osterix, and osteocalcin would provide further details 
regarding the time course and extent of osteoblast differentiation events in response to 
GSK3β inhibition. 
 
In summary, our analysis of the effects of GSK3β inhibition on zebrafish fin regeneration 
showed that enhanced Wnt/β-catenin signaling increased cell proliferation; increased β-
catenin accumulation; augmented expression of Wnt target genes; and increased the 
length of fin regenerates at 4 and 7 dpa.  Taken together, these results indicate that 
zebrafish fin regeneration is a useful model for studying Wnt mediated bone growth and 
repair, and may have clinical implications for the development of new anabolic bone 
growth therapies.  
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Figure 1:  Fin Ray Structure.  A: Whole-mount view of bony ray consisting of 
segmented concave hemirays.  B:  Longitudinal section of fin ray showing fibroblast-like 
cells surround by concaving facing hemirays, which are covered by a single layer of 
osteoblasts. 
 
Knopf, F., Hammond, C., et al. (2011). "Bone regenerates via dedifferentiation of 
osteoblasts in the zebrafish fin." Developmental cell 20(5): 713-724.  
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Figure 2:  Phases of Regeneration.  A:  By 12 hpa, epithelial cells migrate to cover the 
wound and form the wound epidermis.  B1:  Mesenchymal tissues disorganize and 
migrate distally to contribute to blastema formation by 24 hpa.  B2:  A blastema forms at 
the distal tip of each fin ray within 24-48 hpa.  C:  At 48 hpa and beyond, regenerative 
outgrowth occurs as cells of the blastema proliferate, differentiate, and migrate 
proximally to form the new structures of the fin. 
 
Poss, K., Keating, M., et al. (2003). "Tales of regeneration in zebrafish." Developmental 
dynamics : an official publication of the American Association of Anatomists 226(2): 
202-210. 
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Figure 3:  Wnt/β-catenin Signaling Pathway.  A:  In the absence of the Wnt ligand, β-
catenin is phosphorylated by GSK3β and subsequently degraded.  B:  Binding of the Wnt 
ligand to the transmembrane Fz receptor and co-receptors LRP 5/6 activates Dsh which 
in turn inhibits the cytoplasmic “destruction complex” consisting of Axin, APC and 
GSK3β, leading to β-catenin accumulation and activation of Wnt target genes. 
 
Lee, H.C., Kim, M., et al (2006), “Wnt/Frizzled signaling in hepatocellular carcinoma.” 
Frontiers in bioscience (11): 1901–1915,  
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Figure 4:  LSN 2105786 Accelerates Fin Regeneration.  Continuous treatment with 4 
nM and 5 nM LSN 2105786 produced increased regenerate lengths at 4 and 7 dpa 
compared to control fish.  To determine the length of regenerates for each fish, the third, 
fourth and fifth dorsal and ventral fin rays were measured and the average length of the 
regenerate calculated for each fish. *, P < 0.05. 
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Figure 5:  LSN 2105786 Recapitulates Ectopic Wnt Signaling Phenotype.  Embryos 
treated with LSN 2105786 displayed the characteristic small or absent eye phenotype 
observed as a result of ectopic Wnt signaling.  Eye defects varied in severity in a dose 
dependent manner.  
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Figure 6:  In Situ Hybridization of lef1.  At 1 and 2 dpa, lef1 was restricted to the area 
immediately surrounding the blastema in control fins; whereas, 5 nM LSN 2105786 
treated fins showed an expansion of the expression domain as well as intensified staining.  
Staining intensity at 3 dpa was not significantly altered in treated fins compared to 
control fins; however, the expression area was expanded distally in treated fins. 
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Figure 7:  In Situ Hybridization of shh.  shh is expressed in two distinct subsets of cells 
at the distal tip of control fins at 3 dpa. Fins treated continuously with 5 nM LSN 
2105786 showed a more diffuse expression pattern with shh transcripts being detected in 
the tissues proximal to the blastema.  
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Figure 8:  In Situ Hybridization of bmp4.  bmp4 expression was dramatically increased 
in the 5 nM LSN 2105786 treated fins at 3 dpa.  At 4 dpa, bmp4 was robustly expressed 
in the distal most epidermis of treated fins but was not detected in the same region of 
control fins. 
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Figure 9:  In Situ Hybridization of bmp2b.  Expression of bmp2b was not dramatically 
altered in response to 5 nM LSN 2105786 treatment at 3 and 4 dpa.  
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Figure 10:  Cell Proliferation Analysis.  Cell proliferation was analyzed using anti-
phosphorylated histone H3 (PH3) antibody staining.  PH3 positive cells were counted in 
the regenerating tissue of both control and treated fins, and a “nuclei per unit area” value 
was calculated for each fin.  At 1 dpa, the number of PH3 positive cells was not 
dramatically altered in 5 nM LSN2105786 treated fins.  On the 2nd dpa, the number of 
PH3 positive cells was drastically increased in treated fins. **, P < 0.001. 
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Figure 11: Anti-PH3 Staining at 2 dpa.  5 nM LSN 2105786 treatment produced 
increased proliferation throughout the fin at 2 dpa.  Increased anti-PH3 staining was 
observed in both the regenerating tissue as well as the tissues proximal to the amputation 
plane. 
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Figure 12: Immunofluorescence Intensity of Anti-β-catenin Staining.  LSN 2105786 
treatment produced a dose dependent effect on immunofluorescence intensity.  
Immunofluorescence intensity was increased following 6 nM treatment, and decreased 
following 15 nM treatment.  However, statistical analysis did not yield statistically 
significant differences among treatment groups. 
 
